Insight Molecular Diagnostics Inc. (IMDX) Insider Trading

Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Feb 2025.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

Feb 2025

Feb 7, 2025

Get an email when IMDX's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Apr 23 – 27	Broadwood Partners, L.p. Large holder	Bought 6 parts	570,184	$3.56 average	$2.03M	1.5%	Form 4
Apr 16 – 20	Broadwood Capital INC Large holder	Bought 6 parts	182,861	$3.57 average	$653k	0.5%	Form 4
Feb 10	Neal C Bradsher Large holder	Bought 2 parts	521,739	$5.75 average	$3M	2.2%	Form 4
Feb 7, 2025	Andrea S. James Chief Financial Officer	Bought	97,561	$2.05	$200k	182%	Form 4
Feb 7, 2025	Patrick W Smith Large holder	Bought	1,077,600	$2.05	$2.21M	49%	Form 4
Feb 6, 2025	Broadwood Partners, L.p. Large holder	Bought 4 parts	5,165,695	$2.05 average	$10.6M	21%	Form 4
Jan 31, 2025 – Feb 4, 2025	Patrick W Smith Large holder	Bought 2 parts	915	$2.01 average	$2k	<0.1%	Form 4
Jan 29, 2025 – Jan 30, 2025	Patrick W Smith Large holder	Bought 2 parts	4,198	$2.01 average	$8k	0.2%	Form 4
Jan 13, 2025 – Jan 14, 2025	Patrick W Smith Large holder	Bought 3 parts	16,055	$2.12 average	$34k	0.9%	Form 4
Dec 26, 2024	Patrick W Smith Large holder	Bought	90,219	$2.13	$192k	5.4%	Form 4
Dec 26, 2024	Andrew Arno Director	Bought	12,500	$2.11	$26k	16%	Form 4
Dec 5, 2024	Andrea S. James Chief Financial Officer	Bought	20,000	$2.29	$46k	59%	Form 4

Apr 23 – 27
Broadwood Partners, L.p.
Large holder · bought 570,184 at avg $3.56
$2.03M
1.5% of stake
Apr 16 – 20
Broadwood Capital INC
Large holder · bought 182,861 at avg $3.57
$653k
0.5% of stake
Feb 10
Neal C Bradsher
Large holder · bought 521,739 at avg $5.75
$3M
2.2% of stake
Feb 7, 2025
Andrea S. James
Chief Financial Officer · bought 97,561 at $2.05
$200k
182% of stake
Feb 7, 2025
Patrick W Smith
Large holder · bought 1,077,600 at $2.05
$2.21M
49% of stake
Feb 6, 2025
Broadwood Partners, L.p.
Large holder · bought 5,165,695 at avg $2.05
$10.6M
21% of stake
Jan 31, 2025 – Feb 4, 2025
Patrick W Smith
Large holder · bought 915 at avg $2.01
$2k
<0.1% of stake
Jan 29, 2025 – Jan 30, 2025
Patrick W Smith
Large holder · bought 4,198 at avg $2.01
$8k
0.2% of stake
Jan 13, 2025 – Jan 14, 2025
Patrick W Smith
Large holder · bought 16,055 at avg $2.12
$34k
0.9% of stake
Dec 26, 2024
Patrick W Smith
Large holder · bought 90,219 at $2.13
$192k
5.4% of stake
Dec 26, 2024
Andrew Arno
Director · bought 12,500 at $2.11
$26k
16% of stake
Dec 5, 2024
Andrea S. James
Chief Financial Officer · bought 20,000 at $2.29
$46k
59% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch IMDX, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: In Vitro & In Vivo Diagnostic Substances

QCLSQ/C Technologies, Inc.

VNRXVolitionRx Limited

AWHLAspira Women's Health Inc.

BMRABiomerica Inc.

CPMDCannapharmaRx Inc.

SCPXScorpius Holdings Inc.

OVIDOvid Therapeutics Inc.

LPCNLipocine Inc.

Spot a number that looks wrong? Check it in IMDX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing IMDX

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.